Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
Clinical trial NCT00148798 · COMPLETED
Trial details
- NCT number
- NCT00148798
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2007-07-01
- Enrollment
- 1861
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.